Samsun Ceftriaxone Sodium Hydrate Injection 2g
Ceftriaxone Sodium Hydrate 2g
Prescription medication
Samsun Pharmaceutical Co., Ltd.
MFDS item code 201905264 · Notified 2019.07.24 · Insurance code 642307991
Treatment of infections in the respiratory system (pneumonia, bronchitis) and genitourinary system (gonorrhea)
This drug is an effective antibiotic against various types of bacteria, used not only for respiratory infections such as pneumonia and bronchitis but also for ENT infections. Furthermore, it helps in the treatment of kidney and urinary tract infections, gonorrhea, and is widely utilized for the prevention of infection before and after surgery. It is also effective against osteomyelitis, joint infections, skin and soft tissue infections, peritonitis, and cholecystitis. It is applicable for treating infections in immunocompromised patients and is used in the treatment of severe meningitis. Notably, this drug is effective against a variety of resistant strains, including penicillinase-producing organisms, providing reassurance for its use. In summary, this drug is utilized for treating infections from the respiratory system to the skin, urinary tract, genitourinary system, and nervous system.
Adults and children aged 12 years and older should be injected intravenously or intramuscularly with 1 - 2 g (potency) of ceftriaxone once daily. For severe or moderately susceptible infections, the dose can be increased to 4 g (potency) once daily. Elderly patients should follow the adult dosage regimen without modification. For treatment of gonorrhea, a single intramuscular injection of 250 mg (potency) is recommended. For pre- and post-surgical infections,
For neonates (within 14 days of birth), administer 20 - 50 mg/kg (potency) once daily, not exceeding 50 mg (potency). For infants and children (from 15 days to 12 years), administer 20 -
This drug should not be mixed with solutions or drugs containing calcium. Especially in neonates, administering this drug simultaneously with calcium-containing solutions can lead to precipitation in the body, causing severe adverse effects, and should never be done. Patients who have had allergic reactions to this drug, or who have hypersensitivity to cephalosporin or penicillin antibiotics, should not be administered this drug. Furthermore, it should not be used in patients with allergies to certain local anesthetics or in neonates, premature infants, or in neonates with jaundice or hypoalbuminemia. Patients with a history of hypersensitivity or allergies, severely impaired kidney function, elderly patients, and those in poor general condition should be given this drug cautiously, and it may be necessary to adjust the dosage or dosing interval as needed. This drug may cause side effects such as eosinophilia, leukopenia, diarrhea, rash, liver function anomalies, and others, so if any abnormal symptoms appear, notify the healthcare provider immediately. During administration, it is important to regularly check liver function, kidney function, and conduct blood tests to confirm any abnormalities. The safety of this drug during pregnancy has not been fully established, so women who are pregnant or may become pregnant should use it cautiously after consulting a doctor, and caution is also needed during breastfeeding. Be cautious as side effects such as dizziness may occur while driving or operating machinery. When using this drug, follow the duration and dosage prescribed by the doctor to prevent the emergence of resistant bacteria, and avoid unnecessary prolonged use. Additionally, this drug can interact with other medications, so if you are taking other drugs, be sure to inform your healthcare provider.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory difficulties accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container to avoid contact with air, and the storage temperature should be kept between 1 and 30 degrees Celsius (room temperature). By storing it this way, the effectiveness of the drug can be maintained for a longer period.
Vial containing a white to pale yellow powder
10 vials/box (1 vial X 10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ceftriaxone Sodium Hydrate 2g
Prescription medication
Samsun Pharmaceutical Co., Ltd.
Ceftriaxone Sodium Hydrate 1g
Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Ceftriaxone Sodium Hydrate 1g
Prescription medication
Boryung Pharmaceutical Co., Ltd.
Ceftriaxone Sodium Hydrate 0.5g
Prescription medication
(Boryung)
Ceftriaxone Sodium Hydrate 1g
Prescription medication
(Co., Ltd.) Joongheun Pharmaceutical
Ceftriaxone Sodium Hydrate 1g
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Ceftriaxone Sodium Hydrate 500mg
Prescription medication
International Pharmaceutical Co., Ltd.
Ceftriaxone Sodium Hydrate 1g
Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.